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Neurotrophins Live or Let Die: Minireview
Does p75NTR Decide?
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However, enhancing neurotrophin binding is not theCornell University Medical College
only role for p75NTR. A number of reports suggest that itNew York, New York 10021
also modulates trk signaling. While it is clear that trk†Growth Factor and Regeneration Group
signaling can occur in the absence of p75NTR, the re-Department of Neuroscience
sponses are increased in its presence. For example,Max Delbru¨ck Institute for Molecular Medicine
sympathoadrenal cells (MAH cells) expressing only trkABerlin-Buch D-13122
extended neurites and survived in the presence of NGFFederal Republic of Germany
but when coexpressing p75NTR showed an 8-fold higher
tyrosine phosphorylation of trkA (Verdi et al.,1994). Anal-
ysis of transgenic mice lacking p75NTR also supports aThe neurotrophins NGF, BDNF, NT-3, and NT-4/5 are
facilitating role for this receptor in trk function: the doserequired for the survival and differentiation of specific
required to elicit a survival response, at least for NGF,neuronal populations during ontogeny (reviewed by
in primary neurons is four times higher without p75NTRLewin and Barde, 1996). The prototypical member of
(Davies et al., 1993). Clearly, during development, whenthe family, NGF, was shown early on to bind to high and
neurons are competing for limited amounts of target-low affinity sites on neurons, subsequently the receptor
derived trophic factor, a higher sensitivity provides athought to be responsible for low affinity binding was
significant advantage.
cloned (reviewed by Chao, 1994). Much initial work fo- p75NTR Does Its Own Thing
cused on this receptor, which was initially named the
The catalytic forms of the trk receptors are expressed
low affinity NGF receptor and later p75NTR, as it became primarily in neurotrophin-responsive neuronal popula-
clear that it could bind all of the neurotrophins. The tions. p75NTR is often but not always coexpressed in
expansion of the neurotrophin family and the discovery neurons with full-length trk receptors. However, cellular
of a group of cognate receptor tyrosine kinases (Lewin responses to neurotrophins have been seen in cells ex-
and Barde, 1996) left the p75NTR with a seemingly much pressing only p75NTR and no full-length trk (e.g., Schwann
diminished role. However, a series of recent reportshave cells, Anton et al. 1994; Carter et al., 1996), implying
highlighted important and intriguing functions of the the existence of a p75NTR-specific signal. Recent reports
p75NTR; here, we review these new developments and have begun to characterize such a signaling pathway
their implications. and its possible functional significance.
p75NTR as a Helper Receptor p75NTR is a member of a family of structurally related
The p75NTR appears to bind all of the neurotrophins with cytokine receptors, including type I and II TNF receptors
more or less equal affinity but different kinetics; how- (TNFRI and TNFRII), the Fas antigen (also referred to as
Apo1), CD40, CD30, CD27, DR3, and the lymphotoxinever, it was clear early on that it could not account for
b receptor. These receptors are characterized by anthe survival functions exhibited by the neurotrophins.
extracellular domain containing repeated cysteine clus-Later, after the discovery of the trk tyrosine kinase re-
ters. However, the intracellular domains are substan-ceptors (which have the following receptor specificities:
tially divergent and lack any catalytic domain that couldtrkA/NGF, trkB/BDNF and NT-4/5, and TrkC/NT-3), it
provide clues about their mechanisms of action. Thebecame clear that these receptors mediated, to a large
only obvious intracellular homology is a short segmentextent, typicalgrowth factor responses (Bothwell, 1995).
of similarity in Fas and TNFRI referred to as the deathThus, neuronal survival in vitro and in vivo, neurite out-
domain; mutations in this domain abrogate the activa-growth from cultured neurons, and differentiation of
tion of apoptosis by these receptors (Brakebush et al.,PC12 cells could all be best accounted for by activation
1992). Recently, careful alignment analysis has revealedof these receptor tyrosine kinases and their associated
weakly homologous regions in other family members,
signaling pathways (Bothwell, 1995; Lewin and Barde,
including p75NTR, as well as other nonreceptor proteins
1996). It was postulated, however, that the p75NTR played
(Feinstein et al., 1995). The cellular responses to activa-
a crucial role as a coreceptor for the trks. Indeed, sub-
tion of this family of receptors so far characterized are
stantial evidence suggests that this receptor cooperates the activation of gene transcription via nuclear factor k
with trkA to form a high affinity binding site. Several B (NFkB) and the regulation of cell survival/apoptosis.
groups, in particular that of Moses Chao and his col- Several of the receptors have been shown to produce
leagues, demonstrated a need for expression of both the lipid messenger ceramide following agonist binding
receptors in order to produce a high affinity site (Chao, through stimulation of sphingomyelinase. The first clear
1994). In addition, experiments in which binding of NGF biochemical evidence for p75NTR signaling came from
to p75NTR was blocked using either antibodies to p75NTR Dobrowsky et al. (1994) who found that binding of any
or using BDNF (since BDNF can bind p75NTR, but not of the neurotrophins to p75NTR in T9 glioma cells or
trkA) demonstrated a decrease in the number of high NIH3T3 cells also activated sphingomyelinase and sub-
affinity sites in PC12 cells and sensory neurons sequently increased ceramide production.
(Weskamp and Reichardt, 1991; Barker and Shooter, Recently, p75NTR-mediated NFkB activation in Schwann
cells was investigated. These cells are well suited to1994). Thus, p75NTR may facilitate trkA dimerization
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Figure 1. Schematic Representation of the New and Old Models of NGF–p75NTR Interactions
In the old model, p75NTR was seen as simply a helper receptor for the specific neurotrophin receptors, the trks. In the new model, it is clear
that p75NTR has access to its own signaling pathway, which may, in certain cellular contexts, lead to apoptosis. The solid arrow indicates high
affinity binding, and the dashed arrow indicates low affinity. NT, neurotrophin; Jnk, c-jun kinase; and P, phosphate groups.
study p75NTR signaling for several reasons: they express Recently, direct evidence for mediation of cell death
by p75NTR upon NGF binding has been reported by twothe receptor in a regulated manner, they do not express
trkA, and NGF binding to p75NTR elicits their migration groups. Frade et al. (1996) showed that early retinal cells
expressing p75NTR, and not trkA, undergo cell death that(Anton et al., 1994). It was demonstrated that NGF bind-
ing to p75NTR activated nuclear translocation of the p65 could be prevented by application of antibodies to NGF,
thereby demonstrating naturally occurring NGF-medi-subunit of NFkB and stimulated DNA binding. Surpris-
ingly, this activation was specific for NGF; neither NT3 ated apoptosis during chick development via p75NTR.
In a different system, Casaccia-Bonnefil et al. (1996)nor BDNF produced a signal (Carter et al., 1996). The
mechanism for this selectivity is not clear since all of the showed NGF induced apoptosis again through the
p75NTR in cultured rat oligodendrocytes not expressingneurotrophins bind to the receptor with similar affinities.
Moreover, different signaling pathways appear to be trkA. These authors found that the cell death correlated
with a sustained increase in ceramide production andactivated by the different neurotrophins; all have been
shown to activate ceramide production, yet only NGF activation of the c-jun kinase pathway. Strikingly, the
effect was highly specific for NGF and for mature oligo-led to NFkB stimulation.
p75NTR: a Death Receptor? dendrocytes. As was the case for NFkB activation in
Schwann cells, neither NT3 nor BDNF activatedThe similarity of p75NTR/NGF receptor signaling in certain
cell types to cytokine signaling receptors whose activa- apoptosis. In contrast to the oligodendrocytes, NGF did
not stimulate c-jun kinase or programmed cell death intion often leads to apoptotic events led to the rather
heretical notion that the p75NTR can also initiate apop- NIH3T3 cells expressing p75NTR.
The notion that the p75 neurotrophin receptor couldtosis. However, a number of cytokines can function as
trophic or pro-apoptotic signals in the immune system. initiate an apoptotic signal was actually first put forward
several years ago by Bredesen and his colleagues whenOne of the first indications that NGF could mediate neu-
ronal cell death had been suggested by the experiments they observed that expression of p75NTR in specific neu-
roblastoma cell types increased cell death upon with-of von Bartheld et al. (1994) who found that while BDNF
retrogradely transported to chick isthmo-optic nuclei drawal of neurotrophin (Rabizadeh et al., 1993). These
findings led to the proposal of a ligand-independentcould promote the survival of these neurons, NGF in-
creased the number of dying cells. However, this result signal by the receptor, which was blocked by neuro-
trophin binding. Subsequently, Barrett and Bartlettwas interpreted as NGF decreasing binding of endoge-
nous BDNF to trkB by blocking the p75NTR coreceptor, (1994) showed that cultured postnatal mouse dorsal root
ganglion neurons treated with antisense oligonucleo-thus resulting in cell death of some BDNF-dependent
neurons. tides to p75NTR survived longer than controls in the ab-
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sence of neurotrophin, suggesting that the presence of that mature but not immature oligodendrocytes are sus-
ceptible to NGF-induced death. As these cells do notp75NTR is responsible for their apoptosis. The interpreta-
tion of these earlier experiments was, however, compli- express significant levels of p75NTR under normal in vivo
conditions, butdo in lesion models, this finding suggestscated by the possible presence of full-length Trk recep-
tors, a complication more explicitly avoided in recent an apoptotic response function for this receptor in adult
animals.experiments.
New p75NTR Signaling Molecules In vivo data regarding central neurons expressing the
p75NTR (specifically, projection neurons of the septohip-The two-hybrid approach has been successfully used
with a number of receptors in the p75NTR family to identify pocampal system) suggest that the absence of p75NTR
can be neuroprotective during development (Van derunique signaling molecules interacting with their intra-
cellular domains. The group of Goeddel initially isolated Zee et al., 1996). These authors observed an increase
in cholinergic forebrain neurons in mice lacking p75NTRproteins associating with the TNF receptors: TRADD
and TRAF1, 2, and 3 (reviewed by Baker and Reddy, or in wild-type mice injected with a peptide that blocks
NGF binding to p75NTR. The neurons lost appeared to be1996). The TRAF family has continued to grow with three
additional members now identified as receptor inter- those lacking trkA, suggesting that the presence of both
receptors results in an overall survival response. Theactors. A number of the TRAFs interact with other mem-
bers of the p75NTR family, and several have been shown authors suggest that cholinergic neurons possessing
the p75NTR receptor without trkA (reported to be 25% ofto activate NFkB. TRADD appears to be a branch point,
either transducing a death signal to FADD (also called the total) are killed during postnatal development. TrkA
may inhibit the apoptotic signal from p75NTR. Indeed, anMORT1), a protein originally isolated as a Fas antigen
interactor, or activating NFkB via TRAF2. FADD initiates inhibitory effect of trkA on p75NTR-mediated ceramide
production has been reported (Dobrowsky et al., 1995).cell death via MACH (Boldin et al., 1996; also referred
to as FLICE, Muzio et al., 1996), which contains a domain It is notable that NGF is present in the targets of these
cholinergic neurons and perhaps acts throughthe p75NTRwith homology to the ICE family of apoptosis-inducing
proteases. to kill those lacking trkA. What appears to be remarkably
consistent from the published experiments is that theThe multiplicity of these interactors for the othermem-
bers of the p75NTR receptor family of course suggests newly discovered signals mediated by p75NTR appear
to be specific for NGF and are absent with the otherthat the p75NTR may also have access to its own set of
interactors. To investigate the intracellular mechanisms neurotrophins. This specificity has yet to be explained
and was unexpected based on previous binding studiesthrough which p75NTR acts, the yeast two-hybrid system
has also been used to identify a potential signal-trans- with this receptor. An intriguing possibility remains that
a second messenger activated only after NGF bindingducing protein (NRIF) associated with the cytoplasmic
domain of the p75NTR (Carter et al., 1996, Soc. Neurosci. (such as NRIF, for example) could partly account for
such specificity. It is still quite possible that the otherabstract). This novel zinc finger protein associates with
p75NTR in a ligand-dependent manner, which is, interest- neurotrophins might initiate an apoptotic signal through
p75NTR in different cellular contexts where a differentingly, specific for NGF.
New p75NTR Functions: Implications intracellular signal is engaged.
In the above description, we have concentrated onfor Normal Development
The newly identified functions for the p75NTR in a cellular the new pro-apoptotic role for p75NTR. However, the re-
sults of Carter et al. (1996) with Schwann cells showcontext invite one tospeculate whether novel physiolog-
ical roles during normal development and maturity for that NGF can switch on genes via theactivation of p75NTR
and NFkB without leading to cell death. NFkB is a masterNGF/p75NTR signaling have been hitherto overlooked.
Although a new model is suggested by this data (Figure switch regulating the expression of a variety of genes,
some of which may control cell survival. In addition,1), the old model almost certainly still applies in most
situations where p75NTR and full-length trk receptors are this transcription factor is known to upregulate many
adhesion molecules, which could account for the NGF-present. So far, the data suggests that cells can trans-
duce an NGF signal via p75NTR, which could lead to mediated migration of Schwann cells (Anton et al., 1995).
Interestingly, the expression of the adhesion moleculeapoptosis in a very cell type–specific manner. This is
obviously not a prominent feature of target-dependent L1 was reported to be increased by NGF addition to
Schwann cells several years ago (Seilheimer andcell death as NGF is well known to rescue peripheral
NGF-responsive neurons during the period of naturally Schachner, 1987). Thus, one can envisage cases where
p75NTR transduces a more subtle signal in certain cellularoccurring cell death and not to kill them. This fact, to-
gether with reduced neurotrophin binding in the ab- contexts. No doubt more p75NTR-specific regulatory
events will be found in the next phase of neurotrophinsence of p75NTR, probably accounts in large part for the
substantial loss of sensory and sympathetic neurons in research. The new-found Jekyll and Hyde nature of
p75NTR is intriguing as it can promote apoptosis in somethe p75NTR knockout animals (Davies et al., 1993). On the
other hand, the data from the retina (Frade et al., 1996) circumstances, while in other situations it is a neuropro-
tective molecule. In addition, one particularly surprisingsuggests that very early cells, the precise identity of
which is not clear (i.e., postmitotic neurons or neuronal aspect of recent reports is that p75NTR has found a niche
independent of its neurotrophin receptor partners, theprecursors), are susceptible to NGF/p75NTR-induced
death. On the other end of the developmental time scale, trks. Future research will undoubtedly uncover more
intricacies of p75NTR signaling and place them in theirthe observations of Casaccia-Bonnefil et al. (1996) show
Neuron
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proper cellular and physiological contexts during devel-
opment and maturity.
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